Association of Blood Pressure Increases During Hemodialysis With 2-Year Mortality in Incident Hemodialysis Patients: A Secondary Analysis of the Dialysis Morbidity and Mortality Wave 2 Study

被引:145
作者
Inrig, Jula K. [1 ,2 ]
Patel, Uptal D. [2 ,3 ]
Toto, Robert D. [1 ]
Szczech, Lynda A. [2 ,3 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Med, Dallas, TX 75390 USA
[2] Duke Univ, Med Ctr, Dept Med, Durham, NC 27706 USA
[3] Duke Clin Res Inst, Durham, NC USA
基金
美国国家卫生研究院;
关键词
Blood pressure; end-stage renal disease; epidemiology and outcomes; hemodialysis; hypertension; mortality; PARADOXICAL RISE; HYPERTENSION; ULTRAFILTRATION; RECORDINGS; FAILURE; CELLS;
D O I
10.1053/j.ajkd.2009.05.012
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Intradialytic increases in blood pressure (BP) can complicate the management of hypertension in hemodialysis (HD) patents. However, the long-term consequences are uncertain. Thus, we sought to determine whether BP increases during HD were associated with greater 2-year mortality in incident HD patients. Study Design: Secondary analysis of a prospective dialysis cohort. Setting & Participants: Incident HD patients in the Dialysis Morbidity and Mortality Wave 2 Study. Predictors: Changes in systolic BP (SBP) during HD (ie, postdialysis SBP - predialysis SBP), averaged from 3 HD sessions before enrollment. Outcome: Time to 2-year all-cause mortality. Measurements: Cox regression was used to model hazard ratios for mortality associated with changes in SBP during HD while adjusting for demographics, comorbid conditions, interdialytic weight gain, laboratory variables, and anti hypertensive agents. Results: Of 1,748 patients, 12.2% showed greater than 10-mm Hg increases in SBP during HD. In adjusted analyses, every 10-mm Hg increase in SBP during HD was associated independently with a 6% increased hazard of death (hazard ratio, 1.06; 95% confidence interval, 1.01 to 1.11). When also adjusted for diastolic BP and postdialysis SBP, the adjusted hazard of death associated with increasing SBP during HD remained significant (hazard ratio, 1.12; 95% confidence interval, 1.05 to 1.21 per 10-mm Hg increase in SBP during HID). However, in analyses adjusted for predialysis SBP, there was a significant interaction between change in SBP and predialysis SBP. In analyses stratified by predialysis SBP, trends for increased mortality associated with increasing SBP during dialysis were present in patients with predialysis SBP less than 160 mm Hg. However, this relationship was significant only in patients with predialysis SBP less than 120 mm Hg. Limitations: Secondary analysis with a limited number of baseline BP measurements and limited information about dialysis prescription. Conclusions: Increasing SBP by more than 10 mm Hg during HID occurs in approximately 10% of incident patients, and although increasing SBP during HD was associated with decreased 2-year survival, these findings were limited to patients with predialysis SBP less than 120 mm Hg. Am J Kidney Dis 54:881-890. (C) 2009 by the National Kidney Foundation, Inc.
引用
收藏
页码:881 / 890
页数:10
相关论文
共 24 条
[1]   β-Blocker use in long-term dialysis patients -: Association with hospitalized heart failure and mortality [J].
Abbott, KC ;
Trespalacios, FC ;
Agodoa, LY ;
Taylor, A ;
Bakris, GL .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (22) :2465-2471
[2]   Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease [J].
Agarwal, R ;
Andersen, MJ .
KIDNEY INTERNATIONAL, 2006, 69 (07) :1175-1180
[3]   Diagnosing hypertension by intradialytic blood pressure recordings [J].
Agarwal, Rajiv ;
Metiku, Tesfamariam ;
Tegegne, Getachew G. ;
Light, Robert P. ;
Bunaye, Zerihun ;
Bekele, Dagim M. ;
Kelley, Ken .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (05) :1364-1372
[4]   Pre- and postdialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure [J].
Agarwal, Rajiv ;
Peixoto, Aldo J. ;
Santos, Sergio F. F. ;
Zoccali, Carmine .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (03) :389-398
[5]   Cardiovascular Protection With Antihypertensive Drugs in Dialysis Patients Systematic Review and Meta-Analysis [J].
Agarwal, Rajiv ;
Sinha, Arjun D. .
HYPERTENSION, 2009, 53 (05) :860-866
[6]   Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure [J].
Amabile, N ;
Guérin, AP ;
Leroyer, A ;
Mallat, Z ;
Nguyen, C ;
Boddaert, J ;
London, GM ;
Tedgui, A ;
Boulanger, CM .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (11) :3381-3388
[7]  
[Anonymous], LANCET
[8]  
[Anonymous], K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification
[9]   Management of intradialytic hypertension: The ongoing challenge [J].
Chen, J ;
Gul, A ;
Sarnak, MJ .
SEMINARS IN DIALYSIS, 2006, 19 (02) :141-145
[10]   Physiological changes during hemodialysis in patients with intradialysis hypertension [J].
Chou, K-J ;
Lee, P-T ;
Chen, C-L ;
Chiou, C-W ;
Hsu, C-Y ;
Chung, H-M ;
Liu, C-P ;
Fang, H-C .
KIDNEY INTERNATIONAL, 2006, 69 (10) :1833-1838